ISRCTN39361386已完成未知
A randomised multicentre study to compare the Efficacy of additional Tumor DebulKing Surgery versus chemotherapy alone in recurrent Platinum-sensitive Ovarian cancer
AGO Research GmbH (Germany)0 个研究点目标入组 407 人开始时间: 2011年8月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 407
研究概览
简要总结
2017 results presented at ASCO in https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.5501 (added 15/04/2019)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Patients with first recurrence of platinum sensitive, invasive epithelial ovarian-, fallopian tube- or primary peritoneal cancer of any initial stage
- •2. Progression-free interval of at least 6 months after end of last platinum-containing therapy, or recurrence within 6 months or later after primary surgery if the patient has not received prior chemotherapy in patients with International Federation of Gynecology and Obstetrics (FIGO) stage I. Non cytostatic maintenance therapy not containing platinum will not be considered for this calculation
- •3. A positive AGO-score. Obligatory requirements for a positive AGO recurrence score in platinum-sensitive disease: Performance status Eastern Cooperative Oncology Group (ECOG) 0. No residual tumor after primary surgery (if unknown, alternatively primary FIGO stage I / II). If report from 1st surgery is not available contact study chairman who will decide whether inclusion is possible or not. Absence of ascites (cut off < 500 ml: radiological or ultrasound estimation).
- •4. Women aged more than or equal to 18 years
- •5. Complete resection of the tumor by median laparotomy seems possible (estimated by an experienced surgeon). Intra-abdominal disease has to be excluded by magetic resonance imaging (MRI) / computerised tomography (CT) if other surgical approaches for isolated extra-abdominal recurrences are planned
- •6. Patients who have given their signed and written informed consent and their consent to data transmission and -processing
排除标准
- •1. Patients with non-epithelial tumors as well as borderline tumors
- •2. Patients without recurrence who are scheduled for diagnostic/second-look surgery or debulking surgery after completion of chemotherapy
- •3. More than one prior chemotherapy
- •4. Patients with second, third, or later recurrence
- •5. Patients with second malignancies who have been treated by laparotomy, as well as other neoplasms, if the treatment might interfere with the treatment of relapsed ovarian cancer or if major impact on prognosis is expected
- •6. Patients with so-called platinum-refractory tumor, i.e. progression during chemotherapy or recurrence within 6 months after end of former first platinum containing therapy
- •7. Only palliative surgery planned
- •8. Radiological signs suggesting metastases not accessible to surgical removal (i.e. complete resection is deemed impossible)
- •9. Any concomitant disease not allowing surgery and / or chemotherapy
- •10. Any medical history indicating excessive peri-operative risk
- •11. Any current medication inducing considerable surgical risk (e.g. bleeding: due to oral anticoagulating agents, bevacizumab)
研究者
相似试验
已完成
不适用
A prospective, randomised multicentre study comparing cervical anterior discectomy without fusion, with fusion or with arthroplastyCervical disk herniation with radiculopathyMusculoskeletal DiseasesISRCTN41681847Canisius-Wilhelmina Hopsital (CWZ) (The Netherlands)270
已完成
不适用
Pilot randomised trial comparing the effect of different strengths of an antiseptic solution, chlorhexidine gluconate, on central venous catheter related infections in haemodialysis patients in three outpatient haemodialysis centresISRCTN26577745Trinity College Dublin (Ireland)180
终止
4 期
Clopidogrel versus Aspirin in Chronic HEart failureCirculatory SystemHeart failureISRCTN13415258Hull and East Yorkshire Hospitals NHS Trust (UK)87
已完成
不适用
TB Reach 5: to compare the efficacy of video observed treatment (VOT) versus directly observed treatment (DOT) in supporting adherence in patients with active tuberculosisTopic: Respiratory disordersSubtopic: Respiratory (all Subtopics)Disease: RespiratoryInfections and InfestationsTuberculosisISRCTN26184967niversity College London226
已完成
3 期
A multicentre randomised phase III trial comparing Positron Emission Tomography - computed tomography guided watch and wait policy versus planned NECK dissection for the management of locally advanced (N2/N3) nodal metastases in patients with head and neck squamous cancerSquamous cell carcinomaHead and neck squamous cell carcinoma (HNSCC)CancerISRCTN13735240niversity Hospitals Coventry and Warwickshire NHS Trust (UK)560